Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Materials Science & Engineering. C, Materials for Biological Applications
|
March 25, 2020
Biodegradable polymer-nanoclay composites as intestinal sleeve implants installed in digestive tract for obesity and type 2 diabetes treatment
Wei-Hsin Hsu, Hao-Ming Chang, Ya-Lun Lee, et al.
Clinical Pharmacokinetics
|
September 29, 2012
A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects
Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, et al.
Clinical Drug Investigation
|
September 29, 2012
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men
Gary Tong, Lorna Castaneda, Jun-Sheng Wang, et al.
International Journal of Biological Macromolecules
|
May 29, 2026
Surface-engineered heparin- and methoxy poly(ethylene glycol)-modified gelatin microspheres for enhanced extracellular vesicle enrichment
Yu-Ting Tai, Yu-Ting Cheng, Ding-An Li, et al.
British Journal of Clinical Pharmacology
|
May 24, 2012
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Clinical Therapeutics
|
March 3, 2012
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
American Journal of Human Genetics
|
May 20, 2008
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis
Hao-Jie Zhu, Kennerly S Patrick, Hong-Jie Yuan, et al.
ACS Applied Materials & Interfaces
|
January 20, 2026
Enhanced Fuel Cell Performance with Robust Pyridinium-Derivative-Functionalized SBS Triblock Copolymer Anion-Exchange Membranes
Beyadgalem Endawoke Anley, Yohannis Wondwosen Ahmed, Afandi Yusuf, et al.
BMC Medicine
|
December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
Ning Li, Tao Wu, Yong-Gui Hong, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
April 4, 2022
Improvement in the Blood Urea Nitrogen and Serum Creatinine Using New Cultivation of <i>Cordyceps militaris</i>
Chih-Hui Yang, Wen-Shuo Kuo, Jun-Sheng Wang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Materials Science & Engineering. C, Materials for Biological Applications
|
March 25, 2020
Biodegradable polymer-nanoclay composites as intestinal sleeve implants installed in digestive tract for obesity and type 2 diabetes treatment
Wei-Hsin Hsu, Hao-Ming Chang, Ya-Lun Lee, et al.
Clinical Pharmacokinetics
|
September 29, 2012
A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects
Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, et al.
Clinical Drug Investigation
|
September 29, 2012
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men
Gary Tong, Lorna Castaneda, Jun-Sheng Wang, et al.
International Journal of Biological Macromolecules
|
May 29, 2026
Surface-engineered heparin- and methoxy poly(ethylene glycol)-modified gelatin microspheres for enhanced extracellular vesicle enrichment
Yu-Ting Tai, Yu-Ting Cheng, Ding-An Li, et al.
British Journal of Clinical Pharmacology
|
May 24, 2012
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Clinical Therapeutics
|
March 3, 2012
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
American Journal of Human Genetics
|
May 20, 2008
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis
Hao-Jie Zhu, Kennerly S Patrick, Hong-Jie Yuan, et al.
ACS Applied Materials & Interfaces
|
January 20, 2026
Enhanced Fuel Cell Performance with Robust Pyridinium-Derivative-Functionalized SBS Triblock Copolymer Anion-Exchange Membranes
Beyadgalem Endawoke Anley, Yohannis Wondwosen Ahmed, Afandi Yusuf, et al.
BMC Medicine
|
December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
Ning Li, Tao Wu, Yong-Gui Hong, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
April 4, 2022
Improvement in the Blood Urea Nitrogen and Serum Creatinine Using New Cultivation of <i>Cordyceps militaris</i>
Chih-Hui Yang, Wen-Shuo Kuo, Jun-Sheng Wang, et al.
Page
of 8